MohamedMoneeb AbdellatifAzabMD

PubMed

• Moving-Target Defense in Depth: Pervasive Self- and Situation-Aware VM Mobilization across Federated Clouds in Presence of Active Attacks.
  Yousra Magdy, Mohamed Azab, Amal Hamada, Mohamed R M Rizk, Nayera Sadek> ;Sensors. 2022 Dec 6
• UAV-Based Privacy-Preserved Trustworthy Seamless Service Agility for NextG Cellular Networks.
  Mai A Abdel-Malek, Muhammad M Sayed, Mohamed Azab> ;Sensors. 2022 Apr 2
• PeTroShare: Blockchain-Managed, Logistics-Aware, Privacy-Friendly, Comparative, and Efficient Petroleum Transportation.
  Salwa Mohamed Hassan, Mohamed Azab, Amal O. Hamada> ;Sensors. 2021 Oct 25
• The Cost of Guideline Adherence: A Multicenter Analysis of the Financial Implications of Adopting the US Multi-Society Task Force Polypectomy Guidelines.
  Mohamed Azab, Ryan Kahl, Emily Lin, Kelli Kam, Harika Balagoni, Jonathan Pham, Nathan Oh, Marc S. Piper, Andrew P. Wright> ;Journal of Clinical Gastroenterology. 2021 Jul 12
• 51 citations
  Digestive Manifestations in Patients Hospitalized With Coronavirus Disease 2019.
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,...> ;Clinical Gastroenterology and Hepatology. 2021 Jul 1
• 8 citations
  Proton pump inhibitor in upper gastrointestinal fecal microbiota transplant: A systematic review and analysis
  Annie S. Hong, Wen Yuan Yu, Jenny M Hong, Chad L. Cross, Mohamed Azab, Gordon Ohning, Mahendran Jayaraj> ;Journal of Gastroenterology and Hepatology. 2020 Jan 2
• 8 citations
  Autoimmune hepatitis in patients with human immunodeficiency virus infection: A systematic review of the published literature.
  Mohamad Mubder, Mohamed Azab, Mahendran Jayaraj, Chad L. Cross, Daisy S. Lankarani, Banreet S. Dhindsa, Jen Jung Pan, Gordon Ohning> ;Medicine. 2019 Sep 1
• 1 citations
  Identification of novel small molecule inhibitors against the NS3/4A protease of hepatitis C virus genotype 4a.
  Sara M. El-Sayed, Mohamed A. M. Ali, Bahaa El-Dien M. El Gendy, Samar S. Dandash, Yvette Abd El-Sayed Issac, Reda Saad, Mohamed Azab, Mohamed R. Mohamed> ;Current Pharmaceutical Design. 2019 Feb 27
• 2 citations
  Hepatitis C Infection Screening and Management in Opioid Use Epidemics in the United States.
  Xibei Liu, Jay J. Shen, Pearl Kim, Seong-min Park, Sung Youn Chun, Jen Jung Pan, Mohamed Azab, Haneul Choi, Hyeyoung Yeom, Yongjae Lee, Ji Won Yoo> ;The American Journal of Medicine. 2018 Nov 1
• 20 citations
  Safety of endoscopic retrograde cholangiopancreatography (ERCP) in pregnancy: A systematic review and meta-analysis.
  Mohamed Azab, Shishira Bharadwaj, Mahendran Jayaraj, Annie S. Hong, Pejman Solaimani, Mohamad Mubder, Hyeyoung Yeom, Ji Won Yoo, Michael L. Volk> ;Saudi Journal of Gastroenterology. 2018 Jun 1
• Necessity of Interrupted Time Series Analysis in Evaluating the Impact of PHS Risk Identification and Introduction of Direct-Acting Antiviral Therapy and Share 35 Impl...
  Mohamed Azab, Sayed Shah, Xibei Liu, Amaan Shafi, Tamarah Al Dawoodi, Yousif Elmofti, Mary Froehlich, Johnson Ukken, Ji Won Yoo> ;Transplantation. 2018 Jan 1
• More extended indication of DAA therapy in patients with HCC, affordability, and further statistical considerations.
  Devi Tammineedi, Jacob Eisert, Johnson Ukken, Mary Froehlich, Mohamed Azab, Xibei Liu, Ji Won Yoo> ;Journal of Hepatology. 2018 Jan 1
• 5 citations
  Cathepsin K Localizes to Equine Bone In Vivo and Inhibits Bone Marrow Stem and Progenitor Cells Differentiation In Vitro.
  Hayam Hussein, Prosper N. Boyaka, Jennifer Dulin, Duncan S. Russell, Lauren Smanik, Mohamed Azab, Alicia L. Bertone> ;Journal of Stem Cells & Regenerative Medicine. 2017 Dec 18
• 17 citations
  Effects of the 2009 Medical Cannabinoid Legalization Policy on Hospital Use for Cannabinoid Dependency and Persistent Vomiting.
  Mustafa Al-Shammari, Karina Herrera, Xibei Liu, Brandon Gisi, Takashi Yamashita, Kyu Tae Han, Mohamed Azab, Harmeet S. Mashiana, Muthena Maklad, Muhammad T. Farooqui, ...> ;Clinical Gastroenterology and Hepatology. 2017 Dec 1
• 33 citations
  Comparison of the Hospital-Acquired Clostridium difficile Infection Risk of Using Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists for Prophylaxis and Tr...
  Mohamed Azab, Loomee Doo, Daniel H. Doo, Yousif Elmofti, Muazer Ahmed, John Jay P. Cadavona, Xibei B. Liu, Amaan Shafi, Moon Kyung Joo, Ji Won Yoo> ;Gut and Liver. 2017 Nov 15
• 1 citations
  Extended DAA indications for hepatitis C patients awaiting liver transplantation and further statistical considerations.
  Mohamed Azab, S. R. U. Shah, Xibei Liu, Johnson Ukken, Mary Froehlich, Amaan Shafi, Tamarah Al Dawoodi, Caroline Liu, Hyun Phil Shin, Ji Won Yoo> ;Journal of Hepatology. 2017 Oct 1
• 4 citations
  Spontaneous pneumomediastinum: A rare complication of methamphetamine use.
  Jessica Albanese, Cole Gross, Mohamed Azab, Sinziana Mahalean, Ranjit Makar> ;Respiratory Medicine Case Reports. 2017 Mar 10
• 13 citations
  Efficacy and safety of tamsulosin oral-controlled absorption system, solifenacin, and combined therapy for the management of ureteric stent-related symptoms
  Ashraf Abdelaal, Ahmed M. Al-Adl, Shabieb A. Abdelbaki, M. M. Azab, Khaled A. Al Gamal> ;Arab Journal of Urology. 2016 Feb 22
• 1 citations
  NON-INVASIVE PREDICTORS FOR THE PRESENCE, GRADE AND RISK OF BLEEDING FROM ESOPHAGEAL VARICES IN PATIENTS WITH POST-HEPATITIC CIRRHOSIS.
  Ray, A. E., Azab, M. M., El-Aziz, I. M., El-Aleem, A. A., El-Talkawy, M. D., El-Badea, M. A., Ansary, M. E., Safeem, A. A., Diab, T. M.> ;Journal of the Egyptian Society of Parasitology. 2015 Oct 22
• Join now to see all

Abstracts/Posters

• Durable Remission and Long-Term Survival in Relapsed/Refractory (r/r) AML Patients Treated with Guadecitabine, Median Survival Not Reached for Responders after Long Te...
  Mohammad Azab, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Pharmacokinetic Exposure Equivalence and Preliminary Efficacy and Safety from a Randomized Cross over Phase 3 Study (ASCERTAIN study) of an Oral Hypomethylating Agent ...
  Mohammad Azab, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Progression Free Survival (PFS), and Event Free Survival (EFS) from a Global Randomized Phase 3 Study of Guadecitabine (G) Vs Treatment Choice (TC) in 815 Patients wit...
  Mohammad Azab, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Landmark Response and Survival Analyses from 102 MDS and CMML Patients Treated with Guadecitabine in a Phase 2 Study Showing That Maximum Response and Survival Is Best...
  Mohammad Azab, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Landmark Response and Survival Analyses from 206 AML Patients Treated with Guadecitabine in a Phase 2 Study Demonstrate the Importance of Adequate Treatment Duration t...
  Mohammad Azab, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Long Term Results of a Randomized Phase 2 Dose-Response Study of Guadecitabine, a Novel Subcutaneous (SC) Hypomethylating Agent (HMA), in 102 Patients with Intermediat... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018